遺伝子増幅技術市場レポート：2023-2033

Gene Amplification Technologies Market Report 2023-2033

レポート詳細遺伝子増幅技術市場レポート 2023-2033 :本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非常に有益なもの... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
Visiongain ヴィジョンゲイン社	2022年12月5日	GBP4,500 部署ライセンスライセンス・価格情報・注文方法はこちら	425	366	英語

※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

レポート詳細

遺伝子増幅技術市場レポート 2023-2033:本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非常に有益なものとなるでしょう。また、異業種への進出や新地域での既存事業の拡大を目指す企業にとっても有用なレポートです。

ヒトゲノムの全遺伝子を同定・マッピングする遺伝子情報収集の需要増が世界市場拡大の要因に
遺伝子の増幅は、ゲノムのある領域が他の領域と比較して差動的に拡大することである。ほとんどの種がこのプロセスに関与しているようであり、体細胞および生殖細胞の両方で行われることが実証されている。遺伝子の増幅は、成長や生存に役立つといったプラスの効果もあれば、生物にマイナスの効果をもたらすこともある。また、正常な発生過程と関連することもあれば、自然発生的な遺伝子事象として起こることもある。ヒトの悪性腫瘍における体細胞遺伝子の増幅は、最近、重要な研究対象になっている。癌原遺伝子の増幅は、腫瘍の発生を引き起こすか、あるいは寄与している可能性がある。増幅された遺伝子は、時としてがん治療の有効なターゲットとなることがある。増幅された遺伝子は、がん治療のターゲットになることもある。ヒトゲノムのすべての遺伝子を特定し、マッピングするための遺伝子データ収集の需要の高まりが、世界市場の拡大を引き起こしています。遺伝子増幅技術の世界市場は、特定のがん治療法が広く受け入れられていることが要因となっています。ヒトゲノムプロジェクトは、引き続き遺伝子増幅技術（HGP）市場を牽引する主要な要因となっています。

カスタマイズ医療の普及、分子診断学とゲノム研究の拡大が市場を牽引
革新的で最先端の製品の登場、オーダーメイド医療の普及、分子診断学とゲノミクスの研究拡大が、市場の主要な推進要因となっています。近い将来、製薬会社やバイオテクノロジー企業によるゲノミクスへの投資が増加し、業界を大きく活性化すると予測されています。バイオテクノロジー業界では最近、新規医薬品や治療法、ゲノム解読に基づく医薬品、技術開発へのシフトがかなり進んでおり、これが市場拡大を後押ししています。遺伝子増殖技術の商業的な採用は、再現性、精度、時間枠に関して、NGS、液滴デジタルPCR、ゲノムワイドシーケンスなどの分子診断ツールの改善によって影響を受けています。また、遺伝子増倍技術の業界は、アフリカ病原体ゲノムイニシアチブ（アフリカPGI）のような国際プロジェクトによって後押しされています。

マーケットリサーチレポートを購入する前に、どのような質問をすべきでしょうか？
- 遺伝子増幅技術市場はどのように進化しているのか？
- 遺伝子増幅技術市場を牽引し、抑制しているものは何か？
- 各遺伝子増幅技術サブマーケットセグメントは予測期間中にどのように成長し、2033年にこれらのサブマーケットが占める収益はどの程度になるのか？
- 2023年から2033年にかけて、各遺伝子増幅技術サブマーケットの市場シェアはどのように推移するのか？
- 2023年から2033年にかけて、市場全体の主なドライバーは何でしょうか？
- 主要な遺伝子増幅技術市場はマクロ経済のダイナミクスに広く追随するのか、それとも個々の国内市場が他を凌駕するのか？
- 2033年までに各国市場のシェアはどのように変化し、どの地域が2033年の市場をリードするのでしょうか？
- 主要プレイヤーは誰か、予測期間中の展望は？
- これらの主要企業の遺伝子増幅技術プロジェクトはどのようなものですか？
- 2023年から2033年の間に、業界はどのように進化するのか？現在および今後10年間に行われる遺伝子増幅技術プロジェクトにはどのような意味があるのでしょうか？
- 遺伝子増幅技術市場をさらに拡大するために、製品の商業化の必要性は高いか？
- 遺伝子増幅技術市場はどこに向かい、どのようにすれば市場の最前線に立つことができるのか？
- 新製品やサービスラインに対する最適な投資オプションは何か？
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは？

このことが、現在、そして今後10年間の遺伝子増幅技術市場にどのような影響を与えるかを見極める必要があります。

- 425ページにわたる本レポートでは、176の表と190のグラフを独占的に提供します。
- このレポートでは、業界における主要な収益性の高い分野に焦点を当て、お客様が今すぐターゲットにできるような内容になっています。
- 世界、地域、国別の売上高と成長率を詳細に分析しています。
- 競合他社が成功した主要なトレンド、変化、収益予測をハイライトしています。

本レポートは、遺伝子増幅技術市場が今後10年間にどのように発展し、COVID-19の景気後退と回復の変動に沿うかを今日あなたに伝えます。この市場は、過去10年間のどの時点よりも今が重要なのです。

2033年までの予測やその他の分析により、商業的な展望が見えてきた
- 2033年までの収益予測に加え、直近の実績、成長率、市場シェアもご覧いただけます。
- ビジネスの展望や展開など、独自の分析もご覧いただけます。
- 定性的分析（市場力学、促進要因、機会、阻害要因、課題など）、コスト構造、遺伝子増幅技術価格上昇の影響、最近の開発状況などをご覧いただけます。

本レポートでは、COVID-19が業界と貴社にどのような影響を与えるかについて、データ分析と貴重な洞察を掲載しています。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じています。

報告書の対象セグメント

サンプルタイプ別市場セグメント
- 単一細胞
- ホルマリン固定パラフィン包埋（FFPE)

エンドユーザー別市場セグメント
- 製薬会社・バイオテクノロジー企業
- 学術・研究機関
- その他のエンドユーザー

ビジネスタイプ別市場セグメント
- 遺伝子増幅キット・試薬
- 遺伝子増幅器
- 遺伝子増幅サービス
- 遺伝子増幅アンシラリ

用途別市場セグメント
- ハイブリダイゼーション用途
- 全ゲノム用途
- エクソームシーケンス用途
- SNPジェノタイピングアレイ
- アレイCGH

技術別市場セグメント
- PCRベース増幅
- ループ媒介等温増幅
- 核酸配列ベース増幅
- ストランド置換増幅
- 多重置換増幅
- その他の技術

世界市場全体とセグメントの収益予測に加え、4地域と主要20カ国市場の収益予測も掲載しています。

北米
- アメリカ
- カナダ

欧州
- ドイツ
- スペイン
- イギリス
- フランス
- イタリア
- その他の地域

アジア太平洋地域
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋地域

ラテンアメリカ
- ブラジル
- メキシコ
- その他のラテンアメリカ

中近東・アフリカ
- トルコ
- サウジアラビア
- 南アフリカ
- その他の中東・アフリカ

遺伝子増幅技術市場の2023年から2033年までの主要企業のプロファイルと、これらの企業のこのセグメントを中心とした情報も掲載しています。

主要企業と市場成長の可能性
・ 4BASEBIO AG
・ Abbott Laboratories
・ Agilent Technologies, Inc.
・ Ambion Inc.
・ Bayer Pharmaceutics AG
・ Becton Dickinson and Co.
・ Bio-Rad Laboratories
・ Danaher Corporation
・ Illumina Inc.
・ LGC Group
・ Merck KGaA
・ MyBioSource
・ Nanjing Vazyme Biotech Co.
・ New England Biolabs
・ PerkinElmer Inc.
・ Promega Corporation
・ Qiagen N.V.
・ Silicon Biosystems
・ Takara Bio Inc.
・ Yikang Inc.

遺伝子増幅技術市場の世界全体の収益、2023年から2033年まで、金額ベースで2023年に48億5300万米ドルを突破すると、当研究所は計算しています。2033年まで力強い収益成長が予測されます。本調査では、最も大きな可能性を秘めた企業を特定しています。彼らの能力、進歩、商業的展望を知ることで、一歩先を行くことができます。

遺伝子増幅技術市場、2023年から2033年までのレポートはどのように役立つのでしょうか？
420ページを超えるレポートでは、要約すると以下のような知識を得ることができます。

- 遺伝子増幅技術市場の2023年から2033年までの収益予測用途、技術、サンプルタイプ、ビジネスタイプ、エンドユーザー、企業規模の各予測を、世界および地域レベルで掲載 - 産業の展望を見出し、投資と収益に最も有利な場所を見つけることができます。

- 4つの地域と20の主要国市場の2033年までの収益予測 - 遺伝子増幅技術市場、2023年から2033年までの北米、欧州、アジア太平洋、LAMEAの市場予測をご覧いただけます。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなどの主要経済圏の市場も予測されています。

- 遺伝子増幅技術市場に関わる主要企業20社の企業プロファイルを含む、既存企業および市場参入を目指す企業の展望です（2023年から2033年まで）。

定量的・定性的な分析と独自の予測をご覧いただけます。私たちのレポートだけが持つ情報を入手し、貴重なビジネスインテリジェンスを得ることができます。

他にはない情報
私たちの新しいレポートがあれば、知識の遅れを取り戻し、チャンスを逃す可能性が低くなります。私たちの研究が貴社の研究、分析、意思決定にどのように役立つかをご覧ください。Visiongainの研究は、遺伝子増幅技術市場、2023年から2033年、市場をリードする企業のための商業分析を必要とするすべての人のためのものです。データ、トレンド、予測を見つけることができます。

ページTOPに戻る

1.レポートの概要
1.1 研究の目的
1.2 遺伝子増幅技術市場の紹介
1.3 本レポートが提供するもの
1.4 なぜ本レポートを読むべきなのか
1.5 本分析レポートが回答する重要な質問
1.6 本レポートは誰のためのものなのか？
1.7 調査方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.8 よくある質問と回答（FAQ）
1.9 関連するVisiongainのレポート
1.10 Visiongainについて

2 エグゼクティブサマリー

3 プレミアムインサイト
3.1 地理的なスナップショット。遺伝子増幅技術の世界市場
3.2 技術セグメント市場魅力度指数
3.3 サンプルタイプ別セグメント市場魅力度指標
3.4 エンドユーザセグメント市場魅力度指標
3.5 ビジネスタイプ別セグメント市場魅力度指標
3.6 アプリケーションセグメント市場魅力度指標

4 市場の概要
4.1 主要な調査結果
4.2 マーケットダイナミクス
4.2.1 市場の推進要因
4.2.2 市場の抑制要因
4.2.3 市場機会
4.3 サプライチェーンの概要
4.4 バリューチェーンの概要
4.4.1 コールドチェーン
4.5 最近の動向と発展
4.6 COVID-19影響度分析
4.7 ポーターのファイブフォース分析
4.7.1 サプライヤーパワー
4.7.2 バイヤーパワー
4.7.3 競合他社の競争力
4.7.4 代替品による脅威
4.7.5 新規参入の脅威
4.8 環境要因分析
4.8.1 政治的要因
4.8.2 経済的要因
4.8.3 社会的要因
4.8.4 技術的要因
4.8.5 法的要因
4.8.6 環境要因

5 世界の遺伝子増幅技術市場分析：用途別
5.1 主要な調査結果
5.2 世界市場の展望
5.3 地域別の成長展望
5.4 遺伝子増幅技術の世界地域別市場シェア、2023年＆2033年
5.5 遺伝子増幅技術の世界市場シェア予測
5.5.1 COVID-19前の市場シナリオ
5.5.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）
5.6 世界の医薬品受託販売市場の地域別規模推定・予測
5.6.1 COVID-19前の市場シナリオ
5.6.2 ポストCOVID-19市場シナリオ（V、W、U、L字回復分析）

6 世界の遺伝子増幅技術市場分析技：術別別
6.1 主な調査結果
6.2 世界の技術市場の展望
6.3 世界の技術別遺伝子増幅市場魅力度指数
6.4 地域別市場規模の推定と予測
6.5 PCRに基づく増幅
6.5.2 PCRに基づく増幅の世界市場展望
6.5.3 Cleavable Linkersの世界地域別市場展望
6.6 ループを介した等温増幅法
6.7 ループ媒介型等温増幅法の世界市場予測
6.7.1 ループ仲介等温増幅法の世界市場予測：地域別
6.8 核酸配列ベース増幅法
6.8.1 核酸配列ベース増幅の市場予測
6.8.2 核酸配列ベース増幅の世界市場予測：地域別
6.9 ストラントディスプレイスメントアンプリフィケーション
6.8.3 ストランドディスプレイスメントアンプリフィケーションの市場予測
6.8.4 世界のストランドディスプレイスメントアンプの地域別市場予測
6.10 マルチプルディスプレイスメントアンプリフィケーション
6.10.1 Multiple Displacement Amplificationの市場予測
6.8.5 Multiple Displacement Amplificationの世界市場予測：地域別
6.11 その他の技術によるアンプリフィケーション
6.8.6 その他の技術による増幅の市場展望

7世界 遺伝子増幅技術の市場分析試料タイプ別
7.1 主要な調査結果
7.2 サンプルタイプの世界市場展望
7.2.1 サンプルタイプ別遺伝子増幅の世界市場魅力度指数
7.3 サンプルタイプ別ジーンアンプリフィケーション技術の世界市場
7.4 シングルセル
7.4.1 シングルセルの世界市場展望
7.4.2 シングルセルの世界市場予測：地域別
7.5 ホルマリン固定パラフィン包埋（FFPE)
7.5.1 FFPEの世界市場予測
7.5.2 FFPEの世界市場予測、地域別

8 世界の遺伝子増幅技術市場分析：エンドユーザー別
8.1 主な調査結果
8.2 世界のエンドユーザー市場の展望
8.2.1 エンドユーザー別遺伝子増幅の世界市場魅力度指数
8.3 遺伝子増幅技術のエンドユーザー抗原別世界市場
8.4 製薬・バイオテクノロジー企業
8.4.1 医薬品・バイオテクノロジー企業の世界市場予測
8.4.2 製薬・バイオ企業の世界市場予測：地域別
8.5 学術・研究機関
8.5.1 学術・研究機関の世界市場展望
8.5.2 エンドユーザー別学術・研究機関の世界市場展望

9 世界の遺伝子増幅技術市場分析：ビジネスタイプ別別
9.1 主な調査結果
9.2 世界のビジネスタイプ別市場の展望
9.2.1 ビジネスタイプ別別遺伝子増幅の世界市場魅力度指数
9.3 遺伝子増幅技術のビジネスタイプ別世界市場
9.4 キット・試薬
9.4.1 キット＆試薬の世界市場展望
9.4.2 キット・試薬の世界市場：地域別
9.5 インストルメント
9.5.1 インストルメントの世界市場展望
9.5.2 インストルメントの世界市場予測：地域別
9.6 サービス
9.6.1 サービスの世界市場展望
9.6.2 サービスの世界市場予測：地域別
9.7 アンシラリ
9.7.1 アンシラリーの世界市場予測
9.7.2 アンシラリーの世界地域別市場展望

10 北米市場分析
10 北米市場分析
10.1 主要な調査結果
10.2 概要
10.2.2 北米遺伝子増幅技術市場魅力度指数
10.3 北米遺伝子増幅技術市場規模予測：金額別
10.4 北米遺伝子増幅技術市場規模予測・国別予測
10.5 北米遺伝子増幅技術市場規模予測・予測：サンプルタイプ別
10.6 北米遺伝子増幅技術市場のエンドユーザー別市場規模予測・予測
10.7 北米遺伝子増幅技術市場規模予測・予測：ビジネスタイプ別
10.8 北米遺伝子増幅技術市場の用途別市場規模予測・予測
10.9 北米遺伝子増幅技術市場規模予測・予測：技術別
10.10 米国市場
10.10.1 米国政府の外資リスク
10.10.2 アメリカの製薬研究・製造企業
10.11 カナダ市場
10.11.1 研究所が開発した検査の管理
10.11.2 医薬品関連費用

11 欧州市場分析
11.1 主要な調査結果
11.2 概要
11.3 欧州の遺伝子増幅技術市場の魅力度指数
11.5 欧州の遺伝子増幅技術の国別市場規模予測・予想
11.4 欧州の遺伝子増幅技術市場規模予測・金額別予測
11.6 欧州の遺伝子増幅技術市場のサンプルタイプ別市場規模予測・予想
11.7 欧州遺伝子増幅技術市場規模予測・予測：エンドユーザー別
11.8 欧州遺伝子増幅技術市場規模予測・予測：ビジネスタイプ別
11.9 欧州遺伝子増幅技術市場規模予測・用途別予測
11.10 欧州遺伝子増幅技術市場規模予測・予測：技術別
11.2 ドイツ市場
11.2.1 ドイツには強固で幅広い市場がある
11.2.2 発明的なIVD産業
11.3 英国市場
11.3.1 微生物検査のための英国ガイドライン（英国SMI)
11.3.2 NHSは分子遺伝学的分析のための臨床的指向性のある遺伝子検査を利用できるようにした
11.4 フランス市場
11.4.1 フランスの分子診断薬市場の拡大
11.4.2 フランスに投資する外国組織
11.5 イタリア市場
11.5.1 イタリアの製薬会社の優位性
11.5.2 イタリアの核酸増幅技術(NAT)の効果
11.6 スペイン市場
11.6.1 スペインの臨床遺伝学とゲノミクス
11.6.2 スペインの製薬産業と研究開発産業の拡大
11.15 その他の欧州市場分析

12 アジア太平洋地域市場分析
12.1 主な調査結果
12.2 概要
12.2.1 ポリメラーゼ連鎖反応の商業的効果
12.2.2 アジア太平洋地域の遺伝子治療市場
12.3 アジア太平洋地域の遺伝子増幅技術市場の魅力度指数
12.4 アジア太平洋地域の遺伝子増幅技術市場規模推移と予測：金額別
12.5 アジア太平洋地域の遺伝子増幅技術市場規模予測・国別予測
12.6 アジア太平洋地域の遺伝子増幅技術市場市場規模予測・予想サンプルタイプ別
12.7 アジア太平洋地域の遺伝子増幅技術市場規模予測・予測：エンドユーザー別
12.8 アジア太平洋地域遺伝子増幅技術市場規模予測・予測ビジネスタイプ別
12.9 アジア太平洋地域の遺伝子増幅技術の市場規模予測・用途別予測
12.10 アジア太平洋地域の遺伝子増幅技術市場の技術別規模予測・予想
12.3 中国市場
12.3.1 中国の分子診断薬市場は他国より速いスピードで拡大する
12.3.2 分子診断薬の市場セグメント分析
12.4 インド市場
12.4.1 POC診断技術の進歩
12.4.2 インドのゲノム工学技術に関する規制
12.5 日本市場
12.5.1 日本のゲノム医療利用能力
12.5.2 日本の遺伝子検査規制の動向
12.14 韓国市場
12.5.3 韓国における製薬産業の発展
12.6 オーストラリア市場
12.6.1 活動性マイコバクテリア感染のための核酸増幅アッセイ
12.6.2 オーストラリアは世界に広がる生物科学分野のダイナミックな中心地
12.7 その他のアジア太平洋地域の市場分析

13 中東・アフリカ市場分析
13.1 主な調査結果
13.2 概要
13.2.1 拡大する中東・北アフリカ地域の医薬品産業
13.2.2 MENAの規制環境
13.3 中東・アフリカの遺伝子増幅技術市場の魅力度指数
13.4 中東・アフリカの遺伝子増幅技術市場規模推移と予測：金額別
13.5 中東・アフリカの遺伝子増幅技術市場の国別規模予測・予想
13.6 中東・アフリカの遺伝子増幅技術市場サンプルタイプ別規模予測・予想
13.7 中東・アフリカの遺伝子増幅技術市場規模予測・予測：エンドユーザー別
13.8 中東・アフリカの遺伝子増幅技術市場規模予測・ビジネスタイプ別予測
13.9 中東・アフリカの遺伝子増幅技術市場の用途別市場規模予測・予想
13.10 中東・アフリカの遺伝子増幅技術市場の技術別市場規模予測・予想
13.3 南アフリカの市場分析
13.3.1 アフリカ大陸で最大のライフサイエンス市場を持つ南アフリカ共和国
13.4 サウジアラビアの市場分析
13.4.1 サウジアラビアの薬学研究開発
13.4.2 規則と規制
13.5 トルコの市場分析
13.5.1 トルコの規制当局
13.5.2 PCR検査に関する推奨事項の更新
13.6 その他の中東・アフリカ地域の市場分析

14 ラテンアメリカ市場分析
14.1 主な調査結果
14.2 概要
14.2.1 ラテンアメリカの製薬産業の大幅な上昇
14.2.2 他産業との比較と直接的・間接的・誘発的影響の分析
14.3 ラテンアメリカの遺伝子増幅技術市場の魅力度指数
14.4 ラテンアメリカの遺伝子増幅技術市場規模推移と予測：金額別
14.5 ラテンアメリカの遺伝子増幅技術市場規模予測・国別予測
14.6 ラテンアメリカの遺伝子増幅技術市場サンプルタイプ別規模予測・予想
14.7 ラテンアメリカの遺伝子増幅技術市場市場規模予測・予測：エンドユーザー別
14.8 ラテンアメリカの遺伝子増幅技術市場規模予測・ビジネスタイプ別予測
14.9 ラテンアメリカの遺伝子増幅技術市場規模予測・用途別予測
14.10 ラテンアメリカの遺伝子増幅技術市場規模予測・技術別予測
14.11 ブラジル市場
14.2.3 ブラジルのヒト内臓リーシュマニア症診断用LAMPアッセイ開発及び臨床的評価
14.2.4 ブラジル政府の規制と政策
14.3 メキシコ市場
14.3.1 市場環境を利用するメキシコの製薬企業
14.13 その他のラテンアメリカ市場分析

15 競合他社の状況
15.2 主要事業戦略分析-買収
15.3 主要事業戦略分析-契約
15.4 主要事業戦略分析-協業
15.5 主要事業戦略分析-拡大
15.6 主要事業戦略分析-投資
15.7 主要事業戦略分析-新製品上市
15.8 主要事業戦略分析-パートナーシップ
15.9 主要事業戦略分析-開発
15.10 主要事業戦略分析-合弁事業

16 主要企業のプロフィール
16.1 Merck KGaA
16.1.2 企業スナップショット
16.1.3 会社概要
16.1.4 財務分析
16.1.5 製品ベンチマーク
16.1.6 戦略的な展望
16.2 4BASEBIO AG
16.2.1 会社概要
16.2.2 会社概要
16.2.3 財務分析
16.2.4 製品ベンチマーク
16.2.5 戦略的な展望
16.3 Abbott Laboratories (U.S.)
16.3.1 企業スナップショット
16.3.2 会社概要
16.3.3 財務分析
16.3.4 製品ベンチマーク
16.3.5 戦略的な展望
16.4 Agilent Technologies, Inc. (U.S.)
16.4.1 企業スナップショット
16.4.2 会社概要
16.4.3 財務分析
16.4.4 製品ベンチマーク
16.4.5 戦略的な展望
16.5 Ambion Inc.
16.5.1 企業スナップショット
16.5.2 会社概要
16.5.3 ベンチマーキング製品
16.5.4 戦略的展望
16.6 Bayer Pharmaceutics
16.6.1 企業スナップショット
16.6.2 会社概要
16.6.3 財務分析
16.6.4 製品ベンチマーク
16.6.5 戦略的な展望
16.7 Becton Dickinson and Co.
16.7.1 企業スナップショット
16.7.2 会社概要
16.8.4 ベンチマーキング
16.7.3 財務分析
16.7.4 製品ベンチマーク
16.7.5 戦略的展望
16.8 Bio-Rad Laboratories
16.8.1 会社概要
16.8.2 会社概要
16.8.3 財務分析
16.8.5 戦略的展望
16.9 MyBioSource
16.9.1 企業スナップショット
16.9.2 会社概要
16.9.3 製品ベンチマーク
16.9.4 戦略的展望
16.10 Danaher Corporation
16.10.1 企業スナップショット
16.10.2 会社概要
16.10.3 財務分析
16.10.4 製品ベンチマーク
16.10.5 戦略的な展望
16.11 Illumina Inc.
16.11.1 企業スナップショット
16.11.2 会社概要
16.11.3 財務分析
16.11.4 製品ベンチマーキング
16.11.5 戦略的な展望
16.12 LGC Group
16.12.1 企業スナップショット
16.12.2 会社概要
16.12.3 ベンチマーキング
16.12.4 戦略的展望
16.13 Nanjing Vazyme Biotech Co.
16.13.1 企業スナップショット
16.13.3 財務分析
16.13.4 製品ベンチマーク
16.13.5 戦略的展望
16.14 New England Biolabs
16.14.1 企業スナップショット
16.14.2 会社概要
16.14.3 製品ベンチマーク
16.14.4 戦略的展望
16.15 PerkinElmer Inc.
16.15.1 企業スナップショット
16.15.3 財務分析
16.15.4 ベンチマーキング
16.15.5 戦略的展望
16.16 Promega Corporation
16.16.1 企業スナップショット
16.16.2 会社概要
16.16.3 製品ベンチマーキング
16.16.4 戦略的展望
16.17 Qiagen N.V.
16.17.1 企業スナップショット
16.17.3 財務分析
16.17.4 製品ベンチマーク
16.17.5 戦略的展望
16.18 Silicon Biosystems
16.18.1 企業スナップショット
16.18.2 会社概要
16.18.3 ベンチマーキング
16.18.4 戦略的展望
16.19 Takara Bio Inc.
16.19.1 企業スナップショット
16.19.2 会社概要
16.19.3 財務分析
16.19.4 製品ベンチマーク
16.19.5 戦略的展望
16.20 Yikang Inc.
16.20.1 企業スナップショット
16.20.2 会社概要
16.20.3 製品ベンチマーク
16.20.4 戦略的展望

17 結論と提言
17.1 ヴィジョンゲインからの結論
17.2 市場関係者への提言

表の一覧
Table 1 Global Gene Amplification Technologies Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 3 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 4 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 5 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 6 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 7 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 8 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 9 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 10 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 11 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 12 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 13 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 14 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 15 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 16 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 17 Global Gene Amplification Technologies Market by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 18 Global Gene Amplification Technologies Market by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 19 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 20 Global Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 21 Global PCR-based Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 22 Global PCR-based Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 23 Global Loop-mediated Isothermal Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 24 Global Loop-mediated Isothermal Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 25 Global Nucleic Acid Sequence Based Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 26 Global Nucleic Acid Sequence Based Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 27 Global Strand Displacement Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 28 Global Strand Displacement Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 29 Global Multiple Displacement Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 30 Global Multiple Displacement Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 31 Global Other Technology Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 32 Global Other Technology Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 33 Global Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 34 Global Single Cell Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 35 Global Single Cell Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 36 Global Formalin-Fixed & Paraffin-Embedded (FFPE) Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 37 Global Formalin-Fixed & Paraffin-Embedded (FFPE) Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 38 Global Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 39 Global Pharmaceutical & Biotechnology Companies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 40 Global Pharmaceutical & Biotechnology Companies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 41 Global Academic & Research Institutes Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 42 Global Academic & Research Institutes Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 43 Global Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 44 Global Gene Amplification Kits & Reagents Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 45 Global Gene Amplification Kits & Reagents Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 46 Global Gene Amplification Instruments Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 47 Global Gene Amplification Instruments Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 48 Global Gene Amplification Services Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 49 Global Gene Amplification Services Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 50 Global Gene Amplification Ancillaries Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 51 Global Gene Amplification Ancillaries Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 52 North America Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 53 North America Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 54 North America Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 55 North America Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 56 North America Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 57 North America Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 58 North America Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 59 US Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 60 Canada Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 61 Europe Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 62 Europe Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 63 Europe Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 64 Europe Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 65 Europe Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 66 Europe Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 67 Europe Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 68 Germany Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 69 UK Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 70 France Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 71 Italy Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 72 Spain Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 73 Rest of Europe Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 74 Asia-Pacific Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 75 Asia-Pacific Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 76 Asia-Pacific Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 77 Asia-Pacific Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 78 Asia-Pacific Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 79 Asia-Pacific Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 80 Asia-Pacific Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 81 China Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 82 India Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 83 Japan Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 84 South Korea Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 85 Australia Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 86 Rest of Asia-Pacific Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 87 Middle East & Africa Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 88 Middle East & Africa Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 89 Middle East & Africa Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 90 Middle East & Africa Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 91 Middle East & Africa Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 92 Middle East & Africa Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 93 Middle East & Africa Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 94 South Africa Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 95 Saudi Arabia Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 96 Turkey Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 97 Rest of Middle East & Africa Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 98 Latin America Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 99 Latin America Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 100 Latin America Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 101 Latin America Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 102 Latin America Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 103 Latin America Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 104 Latin America Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 105 Brazil Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 106 Mexico Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 107 Rest of Latin America Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 108 Key Business Strategies Adopted by Key Players in Gene Amplification Technologies Market
Table 109 Key Business Strategies Adopted by Key Players in Gene Amplification Technologies Market
Table 110 Key Business Strategies Adopted by Key Players in Global Gene Amplification Technologies Market
Table 111 Key Business Strategies Adopted by Key Players in Global Gene Amplification Technologies Market
Table 112 Key Business Strategies Adopted by Key Players in Global Gene Amplification Technologies Market
Table 113 Key Business Strategies Adopted by Key Players in Gene Amplification Technologies Market
Table 114 Key Business Strategies Adopted by Key Players in Global Gene Amplification Technologies Market
Table 115 Key Business Strategies Adopted by Key Players in Global Gene Amplification Technologies Market
Table 116 Key Business Strategies Adopted by Key Players in Gene Amplification Technologies Market
Table 117 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Merck KGaA: Product Benchmarking
Table 119 Merck KGaA: Strategic Outlook
Table 120 4BASEBIO AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 4BASEBIO AG: Product Benchmarking
Table 122 4BASEBIO AG: Strategic Outlook
Table 123 Abbott Laboratories (U.S.), : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 Abbott Laboratories (U.S.),: Product Benchmarking
Table 125 Abbott Laboratories (U.S.),: Strategic Outlook
Table 126 Agilent Technologies, Inc. (U.S.): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 Agilent Technologies, Inc. (U.S.): Product Benchmarking
Table 128 Agilent Technologies, Inc. (U.S.): Strategic Outlook
Table 129 Ambion Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Ambion Inc.: Product Benchmarking
Table 131 Ambion Inc.: Strategic Outlook
Table 132 Bayer Pharmaceutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 Bayer Pharmaceutics: Product Benchmarking
Table 134 Bayer Pharmaceutics: Strategic Outlook
Table 135 Becton Dickinson and Co.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 136 Bio-Rad Laboratories: Product Benchmarking
Table 137 Becton Dickinson and Co.: Product Benchmarking
Table 138 Becton Dickinson and Co.: Strategic Outlook
Table 139 Bio-Rad Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 140 Bio-Rad Laboratories: Strategic Outlook
Table 141 MyBioSource: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 142 MyBioSource: Product Benchmarking
Table 143 MyBioSource: Strategic Outlook
Table 144 Danaher Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 145 Danaher Corporation: Product Benchmarking
Table 146 Danaher Corporation: Strategic Outlook
Table 147 Illumina Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 148 Illumina Inc: Product Benchmarking
Table 149 Illumina Inc: Strategic Outlook
Table 150 LGC Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 151 LGC Group: Product Benchmarking
Table 152 LGC Group: Strategic Outlook
Table 153 Nanjing Vazyme Biotech Co: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 154 Nanjing Vazyme Biotech Co: Product Benchmarking
Table 155 Nanjing Vazyme Biotech Co: Strategic Outlook
Table 156 New England Biolabs: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 157 New England Biolabs: Product Benchmarking
Table 158 New England Biolabs: Strategic Outlook
Table 159 PerkinElmer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 160 PerkinElmer Inc.: Product Benchmarking
Table 161 PerkinElmer Inc.: Strategic Outlook
Table 162 Promega Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 163 Promega Corporation: Product Benchmarking
Table 164 Promega Corporation: Strategic Outlook
Table 165 Qiagen N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 166 Qiagen N.V.: Product Benchmarking
Table 167 Qiagen N.V.: Strategic Outlook
Table 168 Silicon Biosystems: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 169 Silicon Biosystems: Product Benchmarking
Table 170 Silicon Biosystems: Strategic Outlook
Table 171 Takara Bio Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 172 Takara Bio Inc: Product Benchmarking
Table 173 Takara Bio Inc: Strategic Outlook
Table 174 Yikang Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 175 Yikang Inc.: Product Benchmarking
Table 176 Yikang Inc.: Strategic Outlook

図の一覧
Figure 1 Global Gene Amplification Technologies Market Segmentation
Figure 2 Breakdown of Primary Interviews by Company Type, Designation, & Region
Figure 3 Global Gene Amplification Technologies Market Forecast by Region: Market Attractiveness Index
Figure 4 Global Gene Amplification Technologies Market by Technology: Market Attractiveness Index
Figure 5 Global Gene Amplification Technologies Market by Sample Type: Market Attractiveness Index
Figure 6 Global Gene Amplification Technologies Market by End-User: Market Attractiveness Index
Figure 7 Global Gene Amplification Technologies Market by Business Type: Market Attractiveness Index
Figure 8 Global Gene Amplification Technologies Market by Application: Market Attractiveness Index
Figure 9 Global Gene Amplification Technologies Market: Market Dynamics
Figure 10 Global COVID Impact Analysis: Gene Amplification Technologies Market Recovery Scenarios
Figure 11 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 12 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Figure 13 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (U – Shaped Recovery)
Figure 14 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (U – Shaped Recovery)
Figure 15 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (W – Shaped Recovery)
Figure 16 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 17 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (L – Shaped Recovery)
Figure 18 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 19 Global A Market: Porter’s Five Forces Analysis
Figure 20 Global Gene Amplification Technologies Market: PESTLE Analysis
Figure 21 Global Gene Amplification Technologies Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 22 Global Gene Amplification Technologies Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 23 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 24 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 25 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 26 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 27 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 28 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 29 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 30 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 31 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 32 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 33 Global Gene Amplification by Technology Market Attractiveness Index
Figure 34 Global Gene Amplification Technologies Market Forecast by Technology 2023, 2033 (Revenue, CAGR%)
Figure 35 Global Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%))
Figure 36 Global PCR-based Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 37 Global PCR-based Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 38 Global Loop-mediated Isothermal Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 39 Global Loop-mediated Isothermal Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 40 Global Nucleic Acid Sequence Based Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 41 Global Nucleic Acid Sequence Based Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 42 Global Strand Displacement Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 43 Global Strand Displacement Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 44 Global Multiple Displacement Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 45 Global Multiple Displacement Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 46 Global Other Technology Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 47 Global Other Technology Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 48 Global Gene Amplification by Sample Type Market Attractiveness Index
Figure 49 Global Gene Amplification Technologies Market Forecast by Sample Type 2023, 2033 (Revenue, CAGR%)
Figure 50 Global Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%))
Figure 51 Global Single Cell Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 52 Global Single Cell Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 53 Global Formalin-Fixed & Paraffin-Embedded (FFPE) Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 54 Global Formalin-Fixed & Paraffin-Embedded (FFPE) Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 55 Global Gene Amplification by End-User Market Attractiveness Index
Figure 56 Global Gene Amplification Technologies Market Forecast by End-User 2023, 2033 (Revenue, CAGR%)
Figure 57 Global Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%))
Figure 58 Global Pharmaceutical & Biotechnology Companies Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 59 Global Pharmaceutical & Biotechnology Companies Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 60 Global Academic & Research Institutes Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 61 Global Academic & Research Institutes Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 62 Global Gene Amplification by Business Type Market Attractiveness Index
Figure 63 Global Gene Amplification Technologies Market Forecast by Business Type 2023, 2033 (Revenue, CAGR%)
Figure 64 Global Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%))
Figure 65 Global Gene Amplification Kits & Reagents Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 66 Global Gene Amplification Kits & Reagents Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 67 Global Gene Amplification Instruments Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 68 Global Gene Amplification Instruments Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 69 Global Gene Amplification Services Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 70 Global Gene Amplification Services Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 71 Global Gene Amplification Ancillaries Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 72 Global Gene Amplification Ancillaries Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 73 North America Gene Amplification Technologies Market Attractiveness Index
Figure 74 North America Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 75 North America Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%))
Figure 76 North America Gene Amplification Technologies Market Share Forecast by Country, 2023 & 2033 (%)
Figure 77 North America Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%))
Figure 78 North America Gene Amplification Technologies Market Share Forecast by Sample Type, 2023 & 2033 (%)
Figure 79 North America Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%))
Figure 80 North America Gene Amplification Technologies Market Share Forecast by End-User, 2023 & 2033 (%)
Figure 81 North America Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%))
Figure 82 North America Gene Amplification Technologies Market Share Forecast by Business Type, 2023 & 2033 (%)
Figure 83 North America Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%))
Figure 84 North America Gene Amplification Technologies Market Share Forecast by Application, 2023 & 2033 (%)
Figure 85 North America Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%))
Figure 86 North America Gene Amplification Technologies Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 87 US Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 88 Canada Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 89 Europe Gene Amplification Technologies Market Attractiveness Index
Figure 90 Europe Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%))
Figure 91 Europe Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 92 Europe Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%))
Figure 93 Europe Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%))
Figure 94 Europe Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%))
Figure 95 Europe Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%))
Figure 96 Europe Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%))
Figure 97 Germany Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 98 UK Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 99 France Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 100 Italy Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 101 Spain Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 102 Rest of Europe Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 103 Asia-Pacific Gene Amplification Technologies Market Attractiveness Index
Figure 104 Asia-Pacific Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 105 Asia-Pacific Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%))
Figure 106 Asia-Pacific Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%))
Figure 107 Asia-Pacific Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%))
Figure 108 Asia-Pacific Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%))
Figure 109 Asia-Pacific Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%))
Figure 110 Asia-Pacific Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%))
Figure 111 China Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 112 India Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 113 Japan Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 114 South Korea Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 115 Australia Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 116 Rest of Asia-Pacific Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 117 Middle East & Africa Gene Amplification Technologies Market Attractiveness Index
Figure 118 Middle East & Africa Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 119 Middle East & Africa Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%))
Figure 120 Middle East & Africa Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%))
Figure 121 Middle East & Africa Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%))
Figure 122 Middle East & Africa Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%))
Figure 123 Middle East & Africa Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%))
Figure 124 Middle East & Africa Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%))
Figure 125 South Africa Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 126 Saudi Arabia Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 127 Turkey Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 128 Rest of Middle East & Africa Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 129 Latin America Gene Amplification Technologies Market Attractiveness Index
Figure 130 Latin America Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 131 Latin America Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%))
Figure 132 Latin America Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%))
Figure 133 Latin America Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%))
Figure 134 Latin America Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%))
Figure 135 Latin America Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%))
Figure 136 Latin America Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%))
Figure 137 Brazil Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 138 Mexico Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 139 Rest of Latin America Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 140 Merck KGaA.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 141 Merck KGaA: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 142 Merck KGaA: R&D, 2017-2021 (US$ million, AGR%)
Figure 143 Merck KGaA: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 144 4BASEBIO AG: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 145 4BASEBIO AG: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 146 4BASEBIO AG: R&D, 2017-2021 (US$ million, AGR%)
Figure 147 Abbott Laboratories (U.S.) : Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 148 Abbott Laboratories (U.S.): Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 149 Abbott Laboratories (U.S.),: R&D, 2017-2021 (US$ million, AGR%)
Figure 150 Abbott Laboratories (U.S.): EBITDA, 2017-2021 (US$ million, AGR%)
Figure 151 Agilent Technologies, Inc. (U.S.): Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 152 Agilent Technologies, Inc. (U.S.): Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 153 Agilent Technologies, Inc. (U.S.): R&D, 2017-2021 (US$ million, AGR%)
Figure 154 Agilent Technologies, Inc. (U.S.): EBITDA, 2017-2021 (US$ million, AGR%)
Figure 155 Bayer Pharmaceutics: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 156 Bayer Pharmaceutics: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 157 Bayer Pharmaceutics: R&D, 2017-2021 (US$ million, AGR%)
Figure 158 Bayer Pharmaceutics: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 159 Becton Dickinson and Co.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 160 Becton Dickinson and Co.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 161 Becton Dickinson and Co.: R&D, 2017-2021 (US$ million, AGR%)
Figure 162 Becton Dickinson and Co.: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 163 Bio-Rad Laboratories: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 164 Bio-Rad Laboratories: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 165 Bio-Rad Laboratories: R&D, 2017-2021 (US$ million, AGR%)
Figure 166 Bio-Rad Laboratories: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 167 Danaher Corporation.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 168 Danaher Corporation: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 169 Danaher Corporation: R&D, 2017-2021 (US$ million, AGR%)
Figure 170 Danaher Corporation: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 171 Illumina Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 172 Illumina Inc: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 173 Illumina Inc: R&D, 2017-2021 (US$ million, AGR%)
Figure 174 Illumina Inc: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 175 Nanjing Vazyme Biotech Co: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 176 Nanjing Vazyme Biotech Co: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 177 Nanjing Vazyme Biotech Co: R&D, 2017-2021 (US$ million, AGR%)
Figure 178 Nanjing Vazyme Biotech Co: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 179 PerkinElmer Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 180 PerkinElmer Inc.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 181 PerkinElmer Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 182 PerkinElmer Inc.: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 183 Qiagen N.V.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 184 Qiagen N.V.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 185 Qiagen N.V.: R&D, 2017-2021 (US$ million, AGR%)
Figure 186 Qiagen N.V.: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 187 Takara Bio Inc: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 188 Takara Bio Inc: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 189 Takara Bio Inc: R&D, 2017-2021 (US$ million, AGR%)
Figure 190 Takara Bio Inc: EBITDA, 2017-2021 (US$ million, AGR%)

ページTOPに戻る

Table of Contents

Summary

Report Details

The Gene Amplification Technologies Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

A Rise in Demand for Genetic Data Collecting to Identify and Map Every Gene in the Human Genome Is Causing the Global Market to Expand
Gene amplification is the differential expansion of a certain region of the genome relative to the rest. Most species appear to engage in this process, which has been demonstrated to take place in both somatic and germline cells. Gene Amplification can have positive such as a growth or survival benefit or negative effects on the organism. It can be linked to normal developmental processes or occur as spontaneous genetic events. Somatic cell gene amplification in human malignancies has lately received substantial research. Proto-oncogene amplification may cause or contribute to the development of tumours. The amplified gene may occasionally serve as a viable target for cancer treatment. It mentions the growth of a certain DNA from a very little volume. A rise in demand for genetic data collecting to identify and map every gene in the human genome is causing the global market to expand. The global market for gene amplification technology is being driven by the widespread acceptance of specific cancer therapies. Human Genome Projects continue to be the primary factor driving the market for gene amplification technology (HGP).

The Growing Adoption of Customised Medicine, and Expanding Research in Molecular Diagnostics and Genomics Are the Key Market Drivers
The arrival of fresh and cutting-edge products, the growing adoption of customised medicine, and expanding research in molecular diagnostics and genomics are the key market drivers. In the near future, it is projected that rising genomics investments by pharmaceutical and biotechnology businesses would significantly fuel the industry. The biotechnology industry has recently seen a considerable shift toward novel pharmaceuticals and therapies, medicines based on genome sequencing, and technological developments, which has fuelled market expansion. The commercial adoption of gene multiplication techniques has been affected by improvements in molecular diagnostic tools such as NGS, droplet digital PCR, and genome-wide sequencing with respect to reproducibility, accuracy, and timeframe. The industry for gene multiplication technology has also been boosted by international projects like the Africa Pathogen Genomics Initiative (Africa PGI).

What Questions Should You Ask before Buying a Market Research Report?
• How is the gene amplification technologies market evolving?
• What is driving and restraining the gene amplification technologies market?
• How will each gene amplification technologies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each gene amplification technologies submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading gene amplification technologies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the gene amplification technologies projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of gene amplification technologies projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the gene amplification technologies market?
• Where is the gene amplification technologies market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the gene amplification technologies market today, and over the next 10 years:
• Our 425-page report provides 176 tables and 190 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the gene amplification technologies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising gene amplification technologies prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Market Segment by Sample Type
• Single Cell
• Formalin-Fixed & Paraffin-Embedded (FFPE)

Market Segment by End-User
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Other End-Users

Market Segment by Business Type
• Gene Amplification Kits & Reagents
• Gene Amplification Instruments
• Gene Amplification Services
• Gene Amplification Ancillaries

Market Segment by Application
• Hybridization Application
• Whole Genome Amplification
• Exome Sequencing Amplification
• SNP Genotyping Arrays
• Array CGH

Market Segment by Technology
• PCR-based Amplification
• Loop-mediated Isothermal Amplification
• Nucleic Acid Sequence Based Amplification
• Strand Displacement Amplification
• Multiple Displacement Amplification
• Other Technology

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• Spain
• United Kingdom
• France
• Italy
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa
• Turkey
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

The report also includes profiles and for some of the leading companies in the Gene Amplification Technologies Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• 4BASEBIO AG
• Abbott Laboratories
• Agilent Technologies, Inc.
• Ambion Inc.
• Bayer Pharmaceutics AG
• Becton Dickinson and Co.
• Bio-Rad Laboratories
• Danaher Corporation
• Illumina Inc.
• LGC Group
• Merck KGaA
• MyBioSource
• Nanjing Vazyme Biotech Co.
• New England Biolabs
• PerkinElmer Inc.
• Promega Corporation
• Qiagen N.V.
• Silicon Biosystems
• Takara Bio Inc.
• Yikang Inc.

Overall world revenue for Gene Amplification Technologies Market, 2023 to 2033 in terms of value the market will surpass US$4,853 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Gene Amplification Technologies Market, 2023 to 2033 report help you?
In summary, our 420+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Gene Amplification Technologies Market, 2023 to 2033 Market, with forecasts for application, technology, sample type, business type, end-user and company size, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for four regional and 20 key national markets – See forecasts for the Gene Amplification Technologies Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 20 of the major companies involved in the Gene Amplification Technologies Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Gene Amplification Technologies Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

ページTOPに戻る

Table of Contents

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Gene Amplification Technologies Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Research Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Premium Insights
3.1 Geographical Snapshot: Global Gene Amplification Technologies Market
3.2 Technology Segment: Market Attractiveness Index
3.3 Sample Type Segment: Market Attractiveness Index
3.4 End-User Segment: Market Attractiveness Index
3.5 Business Type Segment: Market Attractiveness Index
3.6 Application Segment: Market Attractiveness Index

4 Market Overview
4.1 Key Findings
4.2 Market Dynamics
4.2.1 Market Driving Factors
4.2.2 Market Restraining Factors
4.2.3 Market Opportunities
4.3 Supply Chain Overview
4.4 Value Chain Overview
4.4.1 Cold Chain
4.5 Recent Trends and Developments
4.6 COVID-19 Impact Analysis
4.7 Porter’s Five Forces Analysis
4.7.1 Supplier Power
4.7.2 Buyer Power
4.7.3 Competitive Rivalry
4.7.4 Threat from Substitutes
4.7.5 Threat of New Entrants
4.8 PESTLE Analysis
4.8.1 Political Factors
4.8.2 Economic Factors
4.8.3 Social Factors
4.8.4 Technological Factors
4.8.5 Legal Factors
4.8.6 Environmental Factors

5 Global Gene Amplification Technologies Market Analysis by Application
5.1 Key Findings
5.2 Global Market Outlook
5.3 Region Segment Growth Prospects
5.4 Global Gene Amplification Technologies Market Share by Region, 2023 & 2033
5.5 Global Gene Amplification Technologies Market Share Forecast
5.5.1 Pre-COVID-19 Market Scenario
5.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
5.6 Global Pharma Contract Sales Market by Region Size Estimation and Forecast
5.6.1 Pre-COVID-19 Market Scenario
5.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

6 Global Gene Amplification Technologies Market Analysis by Technology
6.1 Key Findings
6.2 Global Technology Market Outlook
6.3 Global Gene Amplification by Technology Market Attractiveness Index
6.4 Regional Market Size Estimation and Forecast
6.5 Amplification based on PCR
6.5.2 Global PCR-based Amplification Market Forecast
6.5.3 Global Cleavable Linkers Market Forecast by Region
6.6 Loop-mediated Isothermal Amplification
6.7 Global Loop-mediated Isothermal Amplification Market Forecast
6.7.1 Global Loop-mediated Isothermal Amplification Market Forecast by Region
6.8 Nucleic Acid Sequence Based Amplification
6.8.1 Nucleic Acid Sequence Based Amplification Market Forecast
6.8.2 Global Nucleic Acid Sequence Based Amplification Market Forecast by Region
6.9 Strand Displacement Amplification
6.8.3 Strand Displacement Amplification Market Forecast
6.8.4 Global Strand Displacement Amplification Market Forecast by Region
6.10 Multiple Displacement Amplification
6.10.1 Multiple Displacement Amplification Market Forecast
6.8.5 Global Multiple Displacement Amplification Market Forecast by Region
6.11 Other Technology Amplification
6.8.6 Other Technology Amplification Market Forecast

7 Global Gene Amplification Technologies Market Analysis by Sample Type
7.1 Key Findings
7.2 Global Sample Type Market Outlook
7.2.1 Global Gene Amplification by Sample Type Market Attractiveness Index
7.3 Global Gene Amplification Technologies Market by Sample Type
7.4 Single Cell
7.4.1 Global Single Cell Market Forecast
7.4.2 Global Single Cell Market Forecast by Region
7.5 Formalin-Fixed, Paraffin-Embedded (FFPE)
7.5.1 Global FFPE Market Forecast
7.5.2 Global FFPE Market Forecast by Region

8 Global Gene Amplification Technologies Market Analysis by End-User
8.1 Key Findings
8.2 Global End-User Market Outlook
8.2.1 Global Gene Amplification by End-User Market Attractiveness Index
8.3 Global Gene Amplification Technologies Market by End-User Antigen
8.4 Pharmaceutical & Biotechnological Companies
8.4.1 Global Pharmaceutical & Biotechnological Companies Market Forecast
8.4.2 Global Pharmaceutical & Biotechnological Companies Market Forecast by Region
8.5 Academic & Research Institute
8.5.1 Global Academic & Research Institute Market Forecast
8.5.2 Global Academic & Research Institute Market Forecast by End-User

9 Global Gene Amplification Technologies Market Analysis by Business Type
9.1 Key Findings
9.2 Global Business Type Market Outlook
9.2.1 Global Gene Amplification by Business Type Market Attractiveness Index
9.3 Global Gene Amplification Technologies Market by Business Type
9.4 Kits & Reagents
9.4.1 Global Kits & Reagents Market Forecast
9.4.2 Global Kits & Reagents Market by Region
9.5 Instruments
9.5.1 Global Instruments Market Forecast
9.5.2 Global Instruments Market by Region
9.6 Services
9.6.1 Global Services Market Forecast
9.6.2 Global Services Market by Region
9.7 Ancillaries
9.7.1 Global Ancillaries Market Forecast
9.7.2 Global Ancillaries Market by Region

10 North America Market Analysis
10.1 Key Findings
10.2 Overview
10.2.2 North America Gene Amplification Technologies Market Attractiveness Index
10.3 North America Gene Amplification Technologies Market Size and Forecast by Value
10.4 North Gene Amplification Technologies Market Size Estimation and Forecast by Country
10.5 North America Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
10.6 North America Gene Amplification Technologies Market Size Estimation and Forecast by End-User
10.7 North America Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
10.8 North America Gene Amplification Technologies Market Size Estimation and Forecast by Application
10.9 North America Gene Amplification Technologies Market Size Estimation and Forecast by Technology
10.10 US Market
10.10.1 The US Government's Foreign Investment Risk
10.10.2 The American Pharmaceutical Research and Manufacturers
10.11 Canada Market
10.11.1 Control of Laboratory-Developed Tests
10.11.2 Drug-related Expenses

11 Europe Market Analysis
11.1 Key Findings
11.2 Overview
11.3 Europe Gene Amplification Technologies Market Attractiveness Index
11.5 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Country
11.4 Europe Gene Amplification Technologies Market Size and Forecast by Value
11.6 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
11.7 Europe Gene Amplification Technologies Market Size Estimation and Forecast by End-User
11.8 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
11.9 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Application
11.10 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Technology
11.2 Germany Market
11.2.1 Germany Has a Robust and Broad Market
11.2.2 Inventive IVD industry
11.3 UK Market
11.3.1 UK Guidelines for Microbiology Examinations (UK SMIs)
11.3.2 The NHS Has Made Clinically-Directed Genetic Testing Available for Molecular Genetic Analysis
11.4 France Market
11.4.1 Molecular Diagnostics Market Expansion in France
11.4.2 Foreign Organisations Investing in France
11.5 Italy Market
11.5.1 Italian Pharmaceuticals' Advantage
11.5.2 Nucleic Acid Amplification Technology's (NAT) Effects in Italy
11.6 Spain Market
11.6.1 Spanish Clinical Genetics and Genomics
11.6.2 Expansion of Spain's pharmaceutical and R&D Industries
11.15 Rest of Europe Market Analysis

12 Asia-Pacific Market Analysis
12.1 Key Findings
12.2 Overview
12.2.1 The Commercial Effect of Polymerase Chain Reactions
12.2.2 Asia-Pacific Market for Gene Therapy
12.3 Asia-Pacific Gene Amplification Technologies Market Attractiveness Index
12.4 Asia-Pacific Gene Amplification Technologies Market Size and Forecast by Value
12.5 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Country
12.6 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
12.7 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by End-User
12.8 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
12.9 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Application
12.10 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Technology
12.3 China Market
12.3.1 China's Molecular Diagnostics Market Is Going to Expand At a Faster Rate Than That of Other Nations
12.3.2 Market Segment Analysis for Molecular Diagnostics
12.4 India Market
12.4.1 Advancements in POC Diagnostic Technology
12.4.2 India's Genome Engineering Technology Regulations
12.5 Japan Market
12.5.1 Japan's Ability to Use Genomic Medicine
12.5.2 Developments in Japanese Genetic Testing Regulation
12.14 South Korea Market
12.5.3 Pharmaceutical Industry Development in South Korea
12.6 Australia Market
12.6.1 Nucleic Acid Amplification Assays for Active Mycobacterial Infection
12.6.2 Australia Is a Dynamic Centre for the Biological Sciences with a Worldwide Reach
12.7 Rest of Asia-Pacific Market Analysis

13 Middle East & Africa Market Analysis
13.1 Key Findings
13.2 Overview
13.2.1 MENA's Expanding Pharmaceutical Industry
13.2.2 MENA's Regulatory Environment
13.3 Middle East & Africa Gene Amplification Technologies Market Attractiveness Index
13.4 Middle East & Africa Gene Amplification Technologies Market Size and Forecast by Value
13.5 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Country
13.6 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
13.7 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by End-User
13.8 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
13.9 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Application
13.10 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Technology
13.3 South Africa Market Analysis
13.3.1 On the African Continent, South Africa Has the Biggest Life Sciences Market
13.4 Saudi Arabia Market Analysis
13.4.1 Pharmacy Research and Development of Saudi Arabia
13.4.2 Rules and Regulations
13.5 Turkey Market Analysis
13.5.1 Turkish Regulatory Authority
13.5.2 Updates to the Recommendations for PCR Testing
13.6 Rest of Middle East and Africa Market Analysis

14 Latin America Market Analysis
14.1 Key Findings
14.2 Overview
14.2.1 Significantly Raise in Latin American Pharmaceutical Industry
14.2.2 Comparison with Other Industries and Analysis of the Direct, Indirect, and Induced Impacts
14.3 Latin America Gene Amplification Technologies Market Attractiveness Index
14.4 Latin America Gene Amplification Technologies Market Size and Forecast by Value
14.5 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Country
14.6 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
14.7 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by End-User
14.8 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
14.9 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Application
14.10 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Technology
14.11 Brazil Market
14.2.3 Brazil's Loop-Mediated Isothermal Amplification (LAMP) Assay Development and Clinical Evaluation for the Diagnosis of Human Visceral Leishmaniasis
14.2.4 Brazilian Government Regulations and Policies
14.3 Mexico Market
14.3.1 Mexican Pharmaceutical Firms Take Advantage of Market Circumstances
14.13 Rest of Latin America Market Analysis

15 Competitive Landscape
15.2 Key Business Strategy Analysis- Acquisition
15.3 Key Business Strategy Analysis- Agreement
15.4 Key Business Strategy Analysis- Collaboration
15.5 Key Business Strategy Analysis- Expansion
15.6 Key Business Strategy Analysis- Investment
15.7 Key Business Strategy Analysis- New Product Launch
15.8 Key Business Strategy Analysis- Partnership
15.9 Key Business Strategy Analysis- Development
15.10 Key Business Strategy Analysis- Joint Venture

16 Company Profiles
16.1 Merck KGaA
16.1.2 Company Snapshot
16.1.3 Company Overview
16.1.4 Financial Analysis
16.1.5 Product Benchmarking
16.1.6 Strategic Outlook
16.2 4BASEBIO AG
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Financial Analysis
16.2.4 Product Benchmarking
16.2.5 Strategic Outlook
16.3 Abbott Laboratories (U.S.)
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Financial Analysis
16.3.4 Product Benchmarking
16.3.5 Strategic Outlook
16.4 Agilent Technologies, Inc. (U.S.)
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Financial Analysis
16.4.4 Product Benchmarking
16.4.5 Strategic Outlook
16.5 Ambion Inc.
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Product Benchmarking
16.5.4 Strategic Outlook
16.6 Bayer Pharmaceutics
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Financial Analysis
16.6.4 Product Benchmarking
16.6.5 Strategic Outlook
16.7 Becton Dickinson and Co.
16.7.1 Company Snapshot
16.7.2 Company Overview
16.8.4 Product Benchmarking
16.7.3 Financial Analysis
16.7.4 Product Benchmarking
16.7.5 Strategic Outlook
16.8 Bio-Rad Laboratories
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Financial Analysis
16.8.5 Strategic Outlook
16.9 MyBioSource
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Product Benchmarking
16.9.4 Strategic Outlook
16.10 Danaher Corporation
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Financial Analysis
16.10.4 Product Benchmarking
16.10.5 Strategic Outlook
16.11 Illumina Inc.
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Financial Analysis
16.11.4 Product Benchmarking
16.11.5 Strategic Outlook
16.12 LGC Group
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Product Benchmarking
16.12.4 Strategic Outlook
16.13 Nanjing Vazyme Biotech Co.
16.13.1 Company Snapshot
16.13.3 Financial Analysis
16.13.4 Product Benchmarking
16.13.5 Strategic Outlook
16.14 New England Biolabs
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Product Benchmarking
16.14.4 Strategic Outlook
16.15 PerkinElmer Inc.
16.15.1 Company Snapshot
16.15.3 Financial Analysis
16.15.4 Product Benchmarking
16.15.5 Strategic Outlook
16.16 Promega Corporation
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Product Benchmarking
16.16.4 Strategic Outlook
16.17 Qiagen N.V.
16.17.1 Company Snapshot
16.17.3 Financial Analysis
16.17.4 Product Benchmarking
16.17.5 Strategic Outlook
16.18 Silicon Biosystems
16.18.1 Company Snapshot
16.18.2 Company Overview
16.18.3 Product Benchmarking
16.18.4 Strategic Outlook
16.19 Takara Bio Inc.
16.19.1 Company Snapshot
16.19.2 Company Overview
16.19.3 Financial Analysis
16.19.4 Product Benchmarking
16.19.5 Strategic Outlook
16.20 Yikang Inc.
16.20.1 Company Snapshot
16.20.2 Company Overview
16.20.3 Product Benchmarking
16.20.4 Strategic Outlook

17 Conclusion and Recommendations
17.1 Concluding Remarks from Visiongain
17.2 Recommendations for Market Players

List of Tables
Table 1 Global Gene Amplification Technologies Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 3 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 4 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 5 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 6 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 7 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 8 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 9 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 10 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 11 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 12 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 13 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 14 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 15 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 16 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 17 Global Gene Amplification Technologies Market by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 18 Global Gene Amplification Technologies Market by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 19 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 20 Global Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 21 Global PCR-based Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 22 Global PCR-based Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 23 Global Loop-mediated Isothermal Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 24 Global Loop-mediated Isothermal Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 25 Global Nucleic Acid Sequence Based Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 26 Global Nucleic Acid Sequence Based Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 27 Global Strand Displacement Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 28 Global Strand Displacement Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 29 Global Multiple Displacement Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 30 Global Multiple Displacement Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 31 Global Other Technology Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 32 Global Other Technology Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 33 Global Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 34 Global Single Cell Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 35 Global Single Cell Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 36 Global Formalin-Fixed & Paraffin-Embedded (FFPE) Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 37 Global Formalin-Fixed & Paraffin-Embedded (FFPE) Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 38 Global Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 39 Global Pharmaceutical & Biotechnology Companies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 40 Global Pharmaceutical & Biotechnology Companies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 41 Global Academic & Research Institutes Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 42 Global Academic & Research Institutes Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 43 Global Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 44 Global Gene Amplification Kits & Reagents Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 45 Global Gene Amplification Kits & Reagents Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 46 Global Gene Amplification Instruments Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 47 Global Gene Amplification Instruments Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 48 Global Gene Amplification Services Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 49 Global Gene Amplification Services Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 50 Global Gene Amplification Ancillaries Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 51 Global Gene Amplification Ancillaries Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 52 North America Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 53 North America Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 54 North America Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 55 North America Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 56 North America Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 57 North America Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 58 North America Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 59 US Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 60 Canada Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 61 Europe Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 62 Europe Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 63 Europe Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 64 Europe Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 65 Europe Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 66 Europe Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 67 Europe Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 68 Germany Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 69 UK Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 70 France Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 71 Italy Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 72 Spain Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 73 Rest of Europe Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 74 Asia-Pacific Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 75 Asia-Pacific Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 76 Asia-Pacific Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 77 Asia-Pacific Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 78 Asia-Pacific Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 79 Asia-Pacific Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 80 Asia-Pacific Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 81 China Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 82 India Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 83 Japan Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 84 South Korea Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 85 Australia Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 86 Rest of Asia-Pacific Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 87 Middle East & Africa Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 88 Middle East & Africa Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 89 Middle East & Africa Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 90 Middle East & Africa Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 91 Middle East & Africa Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 92 Middle East & Africa Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 93 Middle East & Africa Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 94 South Africa Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 95 Saudi Arabia Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 96 Turkey Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 97 Rest of Middle East & Africa Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 98 Latin America Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 99 Latin America Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 100 Latin America Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 101 Latin America Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 102 Latin America Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 103 Latin America Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 104 Latin America Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 105 Brazil Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 106 Mexico Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 107 Rest of Latin America Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 108 Key Business Strategies Adopted by Key Players in Gene Amplification Technologies Market
Table 109 Key Business Strategies Adopted by Key Players in Gene Amplification Technologies Market
Table 110 Key Business Strategies Adopted by Key Players in Global Gene Amplification Technologies Market
Table 111 Key Business Strategies Adopted by Key Players in Global Gene Amplification Technologies Market
Table 112 Key Business Strategies Adopted by Key Players in Global Gene Amplification Technologies Market
Table 113 Key Business Strategies Adopted by Key Players in Gene Amplification Technologies Market
Table 114 Key Business Strategies Adopted by Key Players in Global Gene Amplification Technologies Market
Table 115 Key Business Strategies Adopted by Key Players in Global Gene Amplification Technologies Market
Table 116 Key Business Strategies Adopted by Key Players in Gene Amplification Technologies Market
Table 117 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Merck KGaA: Product Benchmarking
Table 119 Merck KGaA: Strategic Outlook
Table 120 4BASEBIO AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 4BASEBIO AG: Product Benchmarking
Table 122 4BASEBIO AG: Strategic Outlook
Table 123 Abbott Laboratories (U.S.), : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 Abbott Laboratories (U.S.),: Product Benchmarking
Table 125 Abbott Laboratories (U.S.),: Strategic Outlook
Table 126 Agilent Technologies, Inc. (U.S.): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 Agilent Technologies, Inc. (U.S.): Product Benchmarking
Table 128 Agilent Technologies, Inc. (U.S.): Strategic Outlook
Table 129 Ambion Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Ambion Inc.: Product Benchmarking
Table 131 Ambion Inc.: Strategic Outlook
Table 132 Bayer Pharmaceutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 Bayer Pharmaceutics: Product Benchmarking
Table 134 Bayer Pharmaceutics: Strategic Outlook
Table 135 Becton Dickinson and Co.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 136 Bio-Rad Laboratories: Product Benchmarking
Table 137 Becton Dickinson and Co.: Product Benchmarking
Table 138 Becton Dickinson and Co.: Strategic Outlook
Table 139 Bio-Rad Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 140 Bio-Rad Laboratories: Strategic Outlook
Table 141 MyBioSource: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 142 MyBioSource: Product Benchmarking
Table 143 MyBioSource: Strategic Outlook
Table 144 Danaher Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 145 Danaher Corporation: Product Benchmarking
Table 146 Danaher Corporation: Strategic Outlook
Table 147 Illumina Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 148 Illumina Inc: Product Benchmarking
Table 149 Illumina Inc: Strategic Outlook
Table 150 LGC Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 151 LGC Group: Product Benchmarking
Table 152 LGC Group: Strategic Outlook
Table 153 Nanjing Vazyme Biotech Co: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 154 Nanjing Vazyme Biotech Co: Product Benchmarking
Table 155 Nanjing Vazyme Biotech Co: Strategic Outlook
Table 156 New England Biolabs: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 157 New England Biolabs: Product Benchmarking
Table 158 New England Biolabs: Strategic Outlook
Table 159 PerkinElmer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 160 PerkinElmer Inc.: Product Benchmarking
Table 161 PerkinElmer Inc.: Strategic Outlook
Table 162 Promega Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 163 Promega Corporation: Product Benchmarking
Table 164 Promega Corporation: Strategic Outlook
Table 165 Qiagen N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 166 Qiagen N.V.: Product Benchmarking
Table 167 Qiagen N.V.: Strategic Outlook
Table 168 Silicon Biosystems: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 169 Silicon Biosystems: Product Benchmarking
Table 170 Silicon Biosystems: Strategic Outlook
Table 171 Takara Bio Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 172 Takara Bio Inc: Product Benchmarking
Table 173 Takara Bio Inc: Strategic Outlook
Table 174 Yikang Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 175 Yikang Inc.: Product Benchmarking
Table 176 Yikang Inc.: Strategic Outlook

List of Figures
Figure 1 Global Gene Amplification Technologies Market Segmentation
Figure 2 Breakdown of Primary Interviews by Company Type, Designation, & Region
Figure 3 Global Gene Amplification Technologies Market Forecast by Region: Market Attractiveness Index
Figure 4 Global Gene Amplification Technologies Market by Technology: Market Attractiveness Index
Figure 5 Global Gene Amplification Technologies Market by Sample Type: Market Attractiveness Index
Figure 6 Global Gene Amplification Technologies Market by End-User: Market Attractiveness Index
Figure 7 Global Gene Amplification Technologies Market by Business Type: Market Attractiveness Index
Figure 8 Global Gene Amplification Technologies Market by Application: Market Attractiveness Index
Figure 9 Global Gene Amplification Technologies Market: Market Dynamics
Figure 10 Global COVID Impact Analysis: Gene Amplification Technologies Market Recovery Scenarios
Figure 11 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 12 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Figure 13 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (U – Shaped Recovery)
Figure 14 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (U – Shaped Recovery)
Figure 15 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (W – Shaped Recovery)
Figure 16 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 17 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (L – Shaped Recovery)
Figure 18 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 19 Global A Market: Porter’s Five Forces Analysis
Figure 20 Global Gene Amplification Technologies Market: PESTLE Analysis
Figure 21 Global Gene Amplification Technologies Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 22 Global Gene Amplification Technologies Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 23 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 24 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 25 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 26 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 27 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 28 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 29 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 30 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 31 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 32 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 33 Global Gene Amplification by Technology Market Attractiveness Index
Figure 34 Global Gene Amplification Technologies Market Forecast by Technology 2023, 2033 (Revenue, CAGR%)
Figure 35 Global Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%))
Figure 36 Global PCR-based Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 37 Global PCR-based Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 38 Global Loop-mediated Isothermal Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 39 Global Loop-mediated Isothermal Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 40 Global Nucleic Acid Sequence Based Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 41 Global Nucleic Acid Sequence Based Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 42 Global Strand Displacement Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 43 Global Strand Displacement Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 44 Global Multiple Displacement Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 45 Global Multiple Displacement Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 46 Global Other Technology Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 47 Global Other Technology Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 48 Global Gene Amplification by Sample Type Market Attractiveness Index
Figure 49 Global Gene Amplification Technologies Market Forecast by Sample Type 2023, 2033 (Revenue, CAGR%)
Figure 50 Global Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%))
Figure 51 Global Single Cell Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 52 Global Single Cell Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 53 Global Formalin-Fixed & Paraffin-Embedded (FFPE) Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 54 Global Formalin-Fixed & Paraffin-Embedded (FFPE) Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 55 Global Gene Amplification by End-User Market Attractiveness Index
Figure 56 Global Gene Amplification Technologies Market Forecast by End-User 2023, 2033 (Revenue, CAGR%)
Figure 57 Global Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%))
Figure 58 Global Pharmaceutical & Biotechnology Companies Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 59 Global Pharmaceutical & Biotechnology Companies Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 60 Global Academic & Research Institutes Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 61 Global Academic & Research Institutes Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 62 Global Gene Amplification by Business Type Market Attractiveness Index
Figure 63 Global Gene Amplification Technologies Market Forecast by Business Type 2023, 2033 (Revenue, CAGR%)
Figure 64 Global Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%))
Figure 65 Global Gene Amplification Kits & Reagents Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 66 Global Gene Amplification Kits & Reagents Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 67 Global Gene Amplification Instruments Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 68 Global Gene Amplification Instruments Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 69 Global Gene Amplification Services Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 70 Global Gene Amplification Services Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 71 Global Gene Amplification Ancillaries Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 72 Global Gene Amplification Ancillaries Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 73 North America Gene Amplification Technologies Market Attractiveness Index
Figure 74 North America Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 75 North America Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%))
Figure 76 North America Gene Amplification Technologies Market Share Forecast by Country, 2023 & 2033 (%)
Figure 77 North America Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%))
Figure 78 North America Gene Amplification Technologies Market Share Forecast by Sample Type, 2023 & 2033 (%)
Figure 79 North America Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%))
Figure 80 North America Gene Amplification Technologies Market Share Forecast by End-User, 2023 & 2033 (%)
Figure 81 North America Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%))
Figure 82 North America Gene Amplification Technologies Market Share Forecast by Business Type, 2023 & 2033 (%)
Figure 83 North America Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%))
Figure 84 North America Gene Amplification Technologies Market Share Forecast by Application, 2023 & 2033 (%)
Figure 85 North America Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%))
Figure 86 North America Gene Amplification Technologies Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 87 US Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 88 Canada Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 89 Europe Gene Amplification Technologies Market Attractiveness Index
Figure 90 Europe Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%))
Figure 91 Europe Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 92 Europe Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%))
Figure 93 Europe Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%))
Figure 94 Europe Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%))
Figure 95 Europe Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%))
Figure 96 Europe Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%))
Figure 97 Germany Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 98 UK Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 99 France Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 100 Italy Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 101 Spain Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 102 Rest of Europe Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 103 Asia-Pacific Gene Amplification Technologies Market Attractiveness Index
Figure 104 Asia-Pacific Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 105 Asia-Pacific Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%))
Figure 106 Asia-Pacific Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%))
Figure 107 Asia-Pacific Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%))
Figure 108 Asia-Pacific Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%))
Figure 109 Asia-Pacific Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%))
Figure 110 Asia-Pacific Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%))
Figure 111 China Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 112 India Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 113 Japan Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 114 South Korea Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 115 Australia Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 116 Rest of Asia-Pacific Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 117 Middle East & Africa Gene Amplification Technologies Market Attractiveness Index
Figure 118 Middle East & Africa Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 119 Middle East & Africa Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%))
Figure 120 Middle East & Africa Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%))
Figure 121 Middle East & Africa Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%))
Figure 122 Middle East & Africa Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%))
Figure 123 Middle East & Africa Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%))
Figure 124 Middle East & Africa Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%))
Figure 125 South Africa Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 126 Saudi Arabia Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 127 Turkey Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 128 Rest of Middle East & Africa Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 129 Latin America Gene Amplification Technologies Market Attractiveness Index
Figure 130 Latin America Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 131 Latin America Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%))
Figure 132 Latin America Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%))
Figure 133 Latin America Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%))
Figure 134 Latin America Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%))
Figure 135 Latin America Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%))
Figure 136 Latin America Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%))
Figure 137 Brazil Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 138 Mexico Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 139 Rest of Latin America Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 140 Merck KGaA.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 141 Merck KGaA: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 142 Merck KGaA: R&D, 2017-2021 (US$ million, AGR%)
Figure 143 Merck KGaA: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 144 4BASEBIO AG: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 145 4BASEBIO AG: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 146 4BASEBIO AG: R&D, 2017-2021 (US$ million, AGR%)
Figure 147 Abbott Laboratories (U.S.) : Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 148 Abbott Laboratories (U.S.): Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 149 Abbott Laboratories (U.S.),: R&D, 2017-2021 (US$ million, AGR%)
Figure 150 Abbott Laboratories (U.S.): EBITDA, 2017-2021 (US$ million, AGR%)
Figure 151 Agilent Technologies, Inc. (U.S.): Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 152 Agilent Technologies, Inc. (U.S.): Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 153 Agilent Technologies, Inc. (U.S.): R&D, 2017-2021 (US$ million, AGR%)
Figure 154 Agilent Technologies, Inc. (U.S.): EBITDA, 2017-2021 (US$ million, AGR%)
Figure 155 Bayer Pharmaceutics: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 156 Bayer Pharmaceutics: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 157 Bayer Pharmaceutics: R&D, 2017-2021 (US$ million, AGR%)
Figure 158 Bayer Pharmaceutics: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 159 Becton Dickinson and Co.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 160 Becton Dickinson and Co.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 161 Becton Dickinson and Co.: R&D, 2017-2021 (US$ million, AGR%)
Figure 162 Becton Dickinson and Co.: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 163 Bio-Rad Laboratories: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 164 Bio-Rad Laboratories: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 165 Bio-Rad Laboratories: R&D, 2017-2021 (US$ million, AGR%)
Figure 166 Bio-Rad Laboratories: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 167 Danaher Corporation.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 168 Danaher Corporation: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 169 Danaher Corporation: R&D, 2017-2021 (US$ million, AGR%)
Figure 170 Danaher Corporation: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 171 Illumina Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 172 Illumina Inc: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 173 Illumina Inc: R&D, 2017-2021 (US$ million, AGR%)
Figure 174 Illumina Inc: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 175 Nanjing Vazyme Biotech Co: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 176 Nanjing Vazyme Biotech Co: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 177 Nanjing Vazyme Biotech Co: R&D, 2017-2021 (US$ million, AGR%)
Figure 178 Nanjing Vazyme Biotech Co: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 179 PerkinElmer Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 180 PerkinElmer Inc.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 181 PerkinElmer Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 182 PerkinElmer Inc.: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 183 Qiagen N.V.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 184 Qiagen N.V.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 185 Qiagen N.V.: R&D, 2017-2021 (US$ million, AGR%)
Figure 186 Qiagen N.V.: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 187 Takara Bio Inc: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 188 Takara Bio Inc: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 189 Takara Bio Inc: R&D, 2017-2021 (US$ million, AGR%)
Figure 190 Takara Bio Inc: EBITDA, 2017-2021 (US$ million, AGR%)

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（バイオ薬物）の最新刊レポート

Visiongain 社の最新刊レポート

本レポートと同じKEY WORD（acid）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

遺伝子増幅技術市場レポート：2023-2033

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（バイオ薬物）の最新刊レポート

Visiongain 社の最新刊レポート

本レポートと同じKEY WORD（acid）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?